Events

Rappel de Mosaic Porcine Aortic Bioprosthesis Model 305 and Medtronic Aortic Obturators/Sizers and iOEA Charts Hazard Alert - MosaicPorcine Aortic Bioprosthesis Model 305 All sizes and configurations ie, Standard and Ultra Recall - Medtronic Aortic Obturators/Sizers and iOEA -indexed Effective Orifice Area Charts

Selon Department of Health, Therapeutic Goods Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à Australia qui a été fabriqué par Medtronic Australasia Pty Ltd.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    RC-2014-RN-00015-1
  • Classe de risque de l'événement
    Class I
  • Date de mise en oeuvre de l'événement
    2014-01-22
  • Pays de l'événement
    Australia
  • Source de l'événement
    DHTGA
  • URL de la source de l'événement
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2014-RN-00015-1
  • Notes / Alertes
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notes supplémentaires dans les données
  • Cause
    The current mosaic aortic bioprosthesis sizing chart and obturators/sizers may contribute in some cases to the selection of a larger than optimal mosaic aortic bioprosthesis. medtronic has determined that the practice of substantial oversizing can lead to the reported cases of higher-than-expected transvalvular gradients post implantation. specifically, considerable oversizing, or implanting a valve substantially larger than the native aortic annulus, may result in the alteration of normal leaflet movement as blood flowing through the native annulus may not properly match the size and/or shape of the inflow of the mosaic aortic bioprosthesis. the higher-than-expected transvalvular gradients (> 25 mmhg) have occurred at a rate of 0.33 percent (3.3 reports per 1000 aortic implants). a subset of these valves were explanted within five years of implantation at an overall occurrence rate of 0.1 percent (1 explant per 1000 aortic implants).
  • Action
    Medtronic is not making any specific patient management recommendations for the patients implanted with the Medtronic Mosaic Aortic Bioprosthesis. Surgeons and cardiologists should continue to follow their patients per their usual practice and in accordance with published guidelines. Medtronic has updated the iEOA Mosaic Aortic Bioprosthesis sizing chart and also, modified the current Mosaic Obturators/Sizers to align with the updated sizing chart. The IFU for the modified Mosaic Obturators/Sizers has been updated to include the new sizing chart (iEOA chart). Medtronic recommends surgeons continue to remain diligent in selecting the appropriate size of Mosaic Aortic Bioprosthesis. Adoption of the updated Mosaic Aortic Bioprosthesis sizing chart (iEOA chart) and Mosaic Obturators/Sizers will facilitate optimal aortic valve size selection. For more details, please see http://www.tga.gov.au/safety/alerts-device-medtronic-bioprosthesis-140128.htm .

Device

Mosaic Porcine Aortic Bioprosthesis Model 305 and Medtronic Aortic Obturators/Sizers and iOEA Cha...
  • Modèle / numéro de série
    Mosaic Porcine Aortic Bioprosthesis Model 305 and Medtronic Aortic Obturators/Sizers and iOEA Charts Hazard Alert - MosaicPorcine Aortic Bioprosthesis Model 305 All sizes and configurations ie, Standard and UltraARTG 145761Recall - Medtronic Aortic Obturators/Sizers and iOEA -indexed Effective Orifice Area Charts Model Numbers: 7305, 7305OD, 7305UXARTG 98977
  • Classification du dispositif
    Cardiovascular Devices
  • Manufacturer
    Medtronic Australasia Pty Ltd

Manufacturer

Medtronic Australasia Pty Ltd
  • Société-mère du fabricant (2017)
    Medtronic plc
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    DHTGA